Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status

World Journal of Surgical Oncology

Rosario Caltabiano²  Aldo Garozzo³  Enrico Vasquez²  Serena Trapasso³  Valeria Zuccal๠ Lidia Puzzo²  Eugenia Allegra³ 

[1] Department of Pathology, University of Catanzaro, Catanzaro, Italy;Department of Pathology, University of Catania, Catania, Italy;Department of Otolaryngology-Head and Neck Surgery, University of Catanzaro, Catanzaro, Italy

关键词: Squamous cell carcinoma;    Lymph node metastasis;    Laryngeal cancer;    BMI-1;   

Others  :  827201
DOI  :  10.1186/1477-7819-10-206

 received in 2012-05-22, accepted in 2012-09-19,  发布年份 2012

【 摘 要 】

Background

The main cause of treatment failure and death in laryngeal squamous cell carcinoma is metastasis to the regional lymph nodes. The current clinical staging criteria fail to differentiate patients with occult metastasis from patients without metastasis. Identifying molecular markers of the disease might improve our understanding of the molecular mechanisms underlying the pathogenesis and development of laryngeal carcinoma and may help improve clinical staging and treatment.

Methods

Sixty-four previously untreated patients who underwent surgical excision of laryngeal squamous cell carcinoma with neck dissection were included in this study. The expression of B cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) was examined immunohistochemically on formalin-fixed paraffin-embedded primary tissue specimens.

Results

Nuclear expression of BMI-1 (nBMI-1) was detected in 32 of the 64 tumors (50%), cytoplasmic expression of BMI-1 (cBMI-1) was detected in 22 (34.4%), and 10 tumors (15.6%) showed no BMI-1 immunoreactivity. High nBMI-1 expression levels (≥10) were detected in 28 of the 32 (87.5%) nBMI-1-positive patients. Multivariate analysis including age at diagnosis, grade, tumor location, TNM status, and nBMI-1 expression showed that a high nBMI-1 expression level was an independent prognostic factor for lymph node metastasis.

Conclusion

The expression of BMI-1 in patients with laryngeal carcinoma seems to correlate with lymph node metastasis.

【 授权许可】

   
2012 Allegra et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781.
• [2]Shah JP, Patel KJ: Head and Neck Surgery and Oncology. 3rd edition. Edinburgh: Mosby; 2003.
• [3]Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ: Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425:962-967.
• [4]Arnes JC, Collett K, Akslen LA: Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. Histopathology 2008, 52:370-380.
• [5]Sangiorgi E, Capecchi MR: Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 2008, 40:915-920.
• [6]Cooper CS, Foster CS: Concepts of epigenetics in prostate cancer development. Br J Cancer 2009, 100:240-245.
• [7]Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, Storz M, Seifert B, Marino S, Schraml P, Dummer R, Moch H: Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer 2007, 121:1764-1770.
• [8]Vrzalikova K, Skarda J, Ehrmann J, Murray PG, Fridman E, Kopolovic J, Knizetova P, Hajduch M, Klein J, Kolek V, Radova L, Kolar Z: Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol 2008, 134:1037-1042.
• [9]Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX: Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 15:6225-6232.
• [10]Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, Christensen R, Han T, Park NH: Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 2007, 96:126-133.
• [11]Chen H, Zhou L, Wan G, Dou T, Tian J: BMI-1 promotes the progression of laryngeal squamous cell carcinoma. Oral Oncol 2011, 47:472-481.
• [12]Huber GF, Albinger-Hegyi A, Soltermann A, Roessle M, Graf N, Haerle SK, Holzmann D, Moch H, Hegyi I: Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer 2011, 17:4659-4670.
• [13]Chiu RJ, Myer EN, Johnson JT: Efficacy of routine neck dissection in the management of supraglottic cancer. Otolaryngol Head Neck Surg 2004, 131:485-488.
• [14]Sten WB, Silver CE, Zeifer BA, Persky MS, Heller KS: Computed tomography of the clinically negative neck. Head Neck 1991, 13:73-75.
• [15]Yucel T, Saatci I, Sennaroglu L, Cekirge S, Aydingoz U, Kaya S: MR imaging in squamous carcinoma of the head and neck with no palpable lymph nodes. Acta Radiol 1997, 38:810-814.
• [16]Kirrchner JA, Carter D: Pathology of the larynx. In Stenberg’s Diagnostic Surgical Pathology. Volume 2. 4th edition. Edited by Mills SE. Noida, India: Gopson Papers Ltd; 2004:1007-1032.
• [17]Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M: Molecular markers in laryngeal squamous carcinoma: towards an integrated clinicobiological approach. Review. Eur J Cancer 2005, 41:683-693.
• [18]Allegra E, Caltabiano R, Amorosi A, Vasquez E, Garozzo A, Puzzo L: Expression of BMI1 and p16 in laringea squamous cell carcinoma. Head Neck 2012. in press(published online)
• [19]Hayry V, Makinen LK, Atula T, Sariola H, Mäkitie A, Leivo I, Keski-Säntti H, Lundin J, Haglund C, Hagström J: Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer 2010, 102:892-897.
• [20]Sayed SI, Dwivedi RC, Katna R, Garg A, Pathak KA, Nutting CM, Rhys-Evans P, Harrington KJ, Kazi R: Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol 2011, 47:237-243.
• [21]Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007, 104:973-978.
• [22]Wang SJ, Wong G, De Heer AM, Xia W, Bourguignon LYW: CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 2009, 119:1518-1530.